United States (US) Deep Vein Thrombosis Market (2025-2031) | Trends, Share, Analysis, Competitive Landscape, Growth, Value, Size & Revenue, Industry, Segmentation, Forecast, Companies, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Deep Vein Thrombosis Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Deep Vein Thrombosis Market - Industry Life Cycle

3.4 United States (US) Deep Vein Thrombosis Market - Porter's Five Forces

3.5 United States (US) Deep Vein Thrombosis Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of deep vein thrombosis (DVT) cases in the United States

4.2.2 Growing awareness about the risks associated with DVT and the need for early diagnosis and treatment

4.2.3 Technological advancements in diagnostic tools and treatment options for DVT

4.3 Market Restraints

4.3.1 High cost of DVT treatment and management, which may limit access to care for some patients

4.3.2 Potential side effects and complications associated with DVT medications and procedures

4.3.3 Stringent regulatory requirements for DVT treatment options, which may slow down the introduction of new therapies

6.1 United States (US) Deep Vein Thrombosis Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Arixtra (Fondaparinux sodium), 2021- 2031F

6.1.4 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Fragmin (Dalteparin sodium), 2021- 2031F

6.1.5 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Eliquis (Apixaban), 2021- 2031F

6.1.6 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Savaysa (Edoxaban), 2021- 2031F

6.1.7 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Xarelto (Rivaroxaban), 2021- 2031F

6.1.8 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Abelacimab, 2021- 2031F

7.1 United States (US) Deep Vein Thrombosis Market Export to Major Countries

7.2 United States (US) Deep Vein Thrombosis Market Imports from Major Countries

8.1 Number of screenings conducted for DVT in the United States

8.2 Adoption rate of minimally invasive DVT treatment procedures

8.3 Patient satisfaction and outcomes post-DVT treatment

8.4 Average time to diagnosis and treatment initiation for DVT patients

8.5 Rate of recurrence of DVT cases

9.1 United States (US) Deep Vein Thrombosis Market Opportunity Assessment, By Drugs, 2021 & 2031F

10.1 United States (US) Deep Vein Thrombosis Market Revenue Share, By Companies, 2024

10.2 United States (US) Deep Vein Thrombosis Market Competitive Benchmarking, By Operating and Technical Parameters